June 7 2018 - Pfizer's PARP inhibitor gets priority review in metastatic breast cancer

June 7 2018 - Pfizer's PARP inhibitor gets priority review in metastatic breast cancer

Pfizer’s PARP inhibitor gets FDA priority review
Swiss won’t investigate Novartis over Cohen payments
The Gates start a nonprofit biotech in Boston
Carl Icahn buys small stake in Allergan
*please scroll down for all the latest news*
*scroll through previous pages at the bottom to get older news*

Our microbiome database currently has 73 conditions for which biome-based products are being developed, & more added regularly. Review products by company, conditions treated, stage of development. Free access w/a subscription to our premium newsletter.


Today's most popular searches:

For banking news and anonymous forums, be sure to check out cafebanking.com

image: